Orhan K Oz
Overview
Explore the profile of Orhan K Oz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kandathil A, Oz O
Q J Nucl Med Mol Imaging
. 2025 Jan;
68(4):227-229.
PMID: 39846363
No abstract available.
2.
Hansen A, Probst S, Beauregard J, Viglianti B, Michalski J, Tagawa S, et al.
Front Oncol
. 2025 Jan;
14():1483953.
PMID: 39839782
Introduction: SPLASH (NCT04647526) is a multicenter phase III trial evaluating the efficacy and safety of [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer (mCRPC). This study leveraged a lead-in phase...
3.
Cheung J, Almonte N, Oz O
Q J Nucl Med Mol Imaging
. 2024 Nov;
68(4):230-244.
PMID: 39589403
Hepatobiliary scintigraphy with single-photon emission computed tomography (SPECT) is an essential Nuclear Medicine exam for assessing hepatobiliary abnormalities and planning therapy. We aim to offer a thorough and all-encompassing analysis...
4.
Co C, Mulgaonkar A, Zhou N, Nguyen T, Harris S, Sherwood A, et al.
ACS Infect Dis
. 2024 Oct;
11(1):144-154.
PMID: 39410659
Orthopedic implant infections (OIIs) present diagnostic and therapeutic challenges, owing to the lack of methods to distinguish between active infection and sterile inflammation. To address this unmet need, d-amino-acid-based radiotracers...
5.
Nguyen N, Anigati E, Desai N, Oz O
Semin Nucl Med
. 2024 May;
54(4):488-496.
PMID: 38772827
Radioactive iodine (RAI) therapy with iodine-131 is performed in select cases of differentiated thyroid cancer (DTC), typically for remnant ablation, adjuvant therapy, or treatment of known persistent disease. Herein, we...
6.
Coye T, Crisologo P, Suludere M, Malone M, Oz O, Lavery L
Int Wound J
. 2024 Mar;
21(3):e14770.
PMID: 38484740
The objective of this paper was to investigate erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) in diagnosing pedal osteomyelitis (OM) in patients with and without diabetes, and with and...
7.
Lavery L, Suludere M, Ryan E, Crisologo P, Tarricone A, Malone M, et al.
Wound Repair Regen
. 2024 Mar;
32(4):360-365.
PMID: 38426336
The aim of this study was to compare outcomes of moderate and severe foot infections in people with and without diabetes mellitus (DM). We retrospectively evaluated 382 patients (77% with...
8.
Suludere M, Oz O, Rogers L, Wukich D, Malone M, Lavery L
Wound Repair Regen
. 2024 Feb;
32(4):377-383.
PMID: 38419162
The aim was to investigate methicillin-resistant Staphylococcus aureus (MRSA) incidence, conversion and outcomes in diabetic foot infections (DFIs). This is a pooled patient-level analysis of combined data sets from two...
9.
Rubitschung K, Sherwood A, Kapadia R, Xi Y, Hajibeigi A, Rubinow K, et al.
PLoS One
. 2024 Feb;
19(2):e0296390.
PMID: 38315701
Estradiol is an important regulator of bone accumulation and maintenance. Circulating estrogens are primarily produced by the gonads. Aromatase, the enzyme responsible for the conversion of androgens to estrogen, is...
10.
Mulgaonkar A, Udayakumar D, Yang Y, Harris S, Oz O, Ramakrishnan Geethakumari P, et al.
Front Med (Lausanne)
. 2023 Jul;
10:1199146.
PMID: 37441689
Chimeric antigen receptor (CAR) T-cell therapies have evolved as breakthrough treatment options for the management of hematological malignancies and are also being developed as therapeutics for solid tumors. However, despite...